UniPharma

therapeutic areas

Urology

Urology is monitored by UniPharma because shifts in demand, reimbursement, regulation, competition, or supply priorities can reshape procurement and launch planning.

Related insights

Latest articles on Urology

April 29, 2026

Nephrology Stents and Catheters Price in the United States: Evidence, Corridors and Buyer Economics

US pricing benchmarks for nephrology stents and catheters: observed list prices, modeled commercial corridors, and landed cost drivers for buyers.

Read insight
April 29, 2026

Laser Fiber Market Forecast 2035: Urology Drives Growth

Global laser fiber market forecast 7.2% CAGR to 2035. Urology drives growth as thulium fiber lasers replace holmium. Single-use kits and GPO consolidation reshape procurement dynamics.

Read insight
April 28, 2026

Neurokinin 3 Receptor Antagonists: A New Non-Hormonal Treatment for ADT-Induced Hot Flushes in Prostate Cancer

Hot flushes from androgen deprivation therapy are underdiagnosed. NK3 receptor antagonists offer a non-hormonal approach with strong mechanistic rationale. What this means for pharma.

Read insight
April 28, 2026

Plasma Proteins Identify Urological Cancer Risk Targets

Mendelian randomisation study identifies plasma protein biomarkers for urological cancers, revealing drug repurposing opportunities and risk stratification potential.

Read insight